[1] 应侠,吴振,雷严,等.阿尔茨海默病的发病机制及治疗药物研究进展[J].中国药房,2014,25(33):3152-3155.
[2] ZHANG Z,ROMAN C G,HONG Z,et al.Parkinson's disease in China:prevalence in Beijing,Xian,and Shanghai[J].Lancet,2005,365(9459):595-597.
[3] LEES A J,HARDY J,REVESZ T.Parkinson's disease[J].Lancet,2009,373(9680):2055-2066.
[4] 于天琦,徐文涛,苏雅娜,等.孟德尔随机化研究基本原理、方法和局限性[J].中国循证医学杂志,2021,21(10):1227-1234.
[5] KUNKLE B W,GRENIER-BOLEY B,SIMS R,et al.Genetic Meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ,tau,immunity and lipid processing[J].Nat Genet,2019,51(3):414-430.
[6] NALLS M A,BLAUWENDRAAT C,VALLERGA C L,et al.Identification of novel risk loci,causal insights,and heritable risk for Parkinson's disease:a Meta-analysis of genome-wide association studies[J].Lancet Neurol,2019,18(12):1091-1102.
[7] EVANS D M,DAVEY SMITH G.Mendelian randomization:new applications in the coming age of hypothesis-free causality[J].Annu Rev Genomics Hum Genet,2015,16:327-350.
[8] CARNEGIE R,ZHENG J,SALLIS H M,et al.Mendelian randomisation for nutritional psychiatry[J].Lancet Psychiatry,2020,7(2):208-216.
[9] 唐伟,徐向楠,符德元. 精神分裂症与乳腺癌之间关联的孟德尔随机化研究[J].现代医学,2024,52(1):96-101.
[10] BURGESS S,BUTTERWORTH A,THOMPSON S G.Mendelian randomization analysis with multiple genetic variants using summarized data[J].Genet Epidemiol,2013,37(7):658-665.
[11] MAGGIO M,LAURETANI F.Prevalence,incidence,and clinical impact of cognitive-motoric risk syndrome in Europe,USA,and Japan:facts and numbers update 2019[J].J Cachexia Sarcopenia Muscle,2019,10(5):953-955.
[12] ALKASIR R,LI J,LI X,et al.Human gut microbiota:the links with dementia development[J].Protein Cell,2017,8(2):90-102.
[13] HU X,WANG T,JIN F.Alzheimer's disease and gut microbiota[J].Sci China Life Sci,2016,59(10):1006-1023.
[14] ERNY D,HRABě DE ANGELIS A L,JAITIN D,et al.Host microbiota constantly control maturation and function of microglia in the CNS[J].Nat Neurosci,2015,18(7):965-977.
[15] DO VAN B,GOUEL F,JONNEAUX A,et al.Ferroptosis,a newly characterized form of cell death in Parkinson's disease that is regulated by PKC[J].Neurobiol Dis,2016,94:169-178.
[16] PRATICÒ D,SUNG S.Lipid peroxidation and oxidative imbalance:early functional events in Alzheimer's disease[J].J Alzheimers Dis,2004,6(2):171-175.
[17] CASTELLANI RJ,MOREIRA PI,LIU G,et al.Iron: the Redox-active center of oxidative stress in Alzheimer disease[J].Neurochem Res,2007,32(10):1640-1645.
[18] SUN J,WANG L,BAO H,et al.Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling[J].Proc Natl Acad Sci U S A,2019,116(23):11113-11115.
[19] CALO L,WEGRZYNOWICZ M,SANTIVAÑEZ-PEREZ J,et al.Synaptic failure and α-synuclein[J].Mov Disord,2016,31(2):169-177.
[20] POLYMEROPOULOS M H,LAVEDAN C,LEROY E,et al.Mutation in the alpha-synuclein gene identified in families with Parkinson's disease[J].Science,1997,276(5321):2045-2047.
[21] AKHTER R.Circular RNA and Alzheimer's disease[J].Adv Exp Med Biol,2018,1087:239-243.
[22] GONZÁLEZ R D,GOMES I,GOMES C,et al.APOE variants in an Iberian Alzheimer cohort detected through an optimized sanger sequencing protocol[J].Genes(Basel), 2020,12(1):4.
[23] 谢笛. BST1基因rs4698412多态性与散发性帕金森病关联研究[D].衡阳:南华大学,2011. |